Saturday, July 11, 2026

pharma · No medical condition. · No medical condition

Tillomed Laboratories

Laboratorios Tillomed Spain is a pharma organization headquartered in EU. Primary therapeutic focus areas include No medical condition., No medical condition, Hormone receptor-positive early breast cancer in post-menopau

Luton, GB HQ
1 Employees
EMA registrant Type
Company details
Clinical program

Levodopa 250mg and Carbidopa 25mg Test Drug tablet

Phase 1 · small molecule · Bioequivalence

Levodopa 250mg and Carbidopa 25mg Test Drug tablet for Bioequivalence is a Phase 1 program (small_molecule) at Laboratorios Tillomed Spain S.L.U with 1 ClinicalTrials.gov record(s).

Internal code HP8813-01

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Laboratorios Tillomed Spain S.L.U
Phase
Phase 1
Modality
small_molecule
Indication
Bioequivalence
Status
completed
Trials
1